Outcome . | Number of Event (%) . | Adjusted Hazard Ratio and 95% CI . | |||||||
---|---|---|---|---|---|---|---|---|---|
SIM vs ATOR . | EZ-SIM vs ATOR . | SIM vs EZ-SIM . | |||||||
SIM (n = 337) . | EZ-SIM (n = 564) . | ATOR (n = 1510) . | HR (95% CI) . | P . | HR (95% CI) . | P . | HR (95% CI) . | P . | |
3-month follow-up | |||||||||
IS | 15 (4.5) | 16 (2.8) | 43 (2.8) | 1.35 (0.73–2.49) | .332 | 0.84 (0.46–1.55) | .576 | 1.61 (0.77–3.36) | .204 |
Death from any cause | 9 (2.7) | 7 (1.2) | 14 (0.9) | 3.14 (1.28–7.74) | .013 | 1.99 (0.76–5.22) | .162 | 1.58 (0.56–4.49) | .391 |
MI | 0 (0.0) | 3 (0.5) | 0 (0.0) | NA | NA | NA | NA | NA | NA |
Composite endpointa | 25 (7.4) | 25 (4.4) | 60 (4.0) | 1.62 (1.01–2.63) | .051 | 1.05 (0.65–1.72) | .836 | 1.54 (0.87–2.74) | .139 |
1-year follow-up | |||||||||
IS | 42 (12.5) | 42 (7.4) | 92 (6.1) | 1.91 (1.31–2.79) | .001 | 1.16 (0.80–1.70) | .439 | 1.64 (1.06–2.56) | .028 |
Death from any cause | 26 (7.7) | 20 (3.5) | 75 (5.0) | 1.56 (0.98–2.48) | .060 | 0.88 (0.53–1.46) | .616 | 1.78 (0.98–3.24) | .060 |
MI | 3 (0.9) | 6 (1.1) | 8 (0.5) | 1.47 (0.36–5.93) | .593 | 2.10 (0.66–6.71) | .211 | 0.70 (0.16–3.02) | .630 |
Composite endpointa | 67 (19.9) | 64 (11.3) | 173 (11.5) | 1.64 (1.23–2.20) | .001 | 1.04 (0.77–1.40) | .808 | 1.59 (1.11–2.26) | .011 |
Overall follow-up | |||||||||
IS | 57 (16.9) | 52 (9.2) | 114 (7.5) | 2.03 (1.46–2.82) | <.001 | 1.20 (0.85–1.69) | .296 | 1.69 (1.14–2.50) | .008 |
Death from any cause | 41 (12.2) | 35 (6.2) | 124 (8.2) | 1.26 (0.87–1.81) | .225 | 0.81 (0.55–1.20) | .297 | 1.54 (0.97–2.46) | .067 |
MI | 7 (2.1) | 6 (1.1) | 16 (1.1) | 1.71 (0.68–4.31) | .259 | 0.96 (0.36–2.58) | .942 | 1.77 (0.58–5.44) | .320 |
Composite endpointa | 95 (28.2) | 87 (15.4) | 243 (16.1) | 1.55 (1.22–1.99) | <.001 | 1.00 (0.77–1.28) | .978 | 1.56 (1.16–2.11) | .004 |
Outcome . | Number of Event (%) . | Adjusted Hazard Ratio and 95% CI . | |||||||
---|---|---|---|---|---|---|---|---|---|
SIM vs ATOR . | EZ-SIM vs ATOR . | SIM vs EZ-SIM . | |||||||
SIM (n = 337) . | EZ-SIM (n = 564) . | ATOR (n = 1510) . | HR (95% CI) . | P . | HR (95% CI) . | P . | HR (95% CI) . | P . | |
3-month follow-up | |||||||||
IS | 15 (4.5) | 16 (2.8) | 43 (2.8) | 1.35 (0.73–2.49) | .332 | 0.84 (0.46–1.55) | .576 | 1.61 (0.77–3.36) | .204 |
Death from any cause | 9 (2.7) | 7 (1.2) | 14 (0.9) | 3.14 (1.28–7.74) | .013 | 1.99 (0.76–5.22) | .162 | 1.58 (0.56–4.49) | .391 |
MI | 0 (0.0) | 3 (0.5) | 0 (0.0) | NA | NA | NA | NA | NA | NA |
Composite endpointa | 25 (7.4) | 25 (4.4) | 60 (4.0) | 1.62 (1.01–2.63) | .051 | 1.05 (0.65–1.72) | .836 | 1.54 (0.87–2.74) | .139 |
1-year follow-up | |||||||||
IS | 42 (12.5) | 42 (7.4) | 92 (6.1) | 1.91 (1.31–2.79) | .001 | 1.16 (0.80–1.70) | .439 | 1.64 (1.06–2.56) | .028 |
Death from any cause | 26 (7.7) | 20 (3.5) | 75 (5.0) | 1.56 (0.98–2.48) | .060 | 0.88 (0.53–1.46) | .616 | 1.78 (0.98–3.24) | .060 |
MI | 3 (0.9) | 6 (1.1) | 8 (0.5) | 1.47 (0.36–5.93) | .593 | 2.10 (0.66–6.71) | .211 | 0.70 (0.16–3.02) | .630 |
Composite endpointa | 67 (19.9) | 64 (11.3) | 173 (11.5) | 1.64 (1.23–2.20) | .001 | 1.04 (0.77–1.40) | .808 | 1.59 (1.11–2.26) | .011 |
Overall follow-up | |||||||||
IS | 57 (16.9) | 52 (9.2) | 114 (7.5) | 2.03 (1.46–2.82) | <.001 | 1.20 (0.85–1.69) | .296 | 1.69 (1.14–2.50) | .008 |
Death from any cause | 41 (12.2) | 35 (6.2) | 124 (8.2) | 1.26 (0.87–1.81) | .225 | 0.81 (0.55–1.20) | .297 | 1.54 (0.97–2.46) | .067 |
MI | 7 (2.1) | 6 (1.1) | 16 (1.1) | 1.71 (0.68–4.31) | .259 | 0.96 (0.36–2.58) | .942 | 1.77 (0.58–5.44) | .320 |
Composite endpointa | 95 (28.2) | 87 (15.4) | 243 (16.1) | 1.55 (1.22–1.99) | <.001 | 1.00 (0.77–1.28) | .978 | 1.56 (1.16–2.11) | .004 |
The HRs were adjusted for all covariates listed in Table 1 and Supplemental Table 2. NA, not applicable.
Any one of IS, HS, cardiovascular death, or MI.
Outcome . | Number of Event (%) . | Adjusted Hazard Ratio and 95% CI . | |||||||
---|---|---|---|---|---|---|---|---|---|
SIM vs ATOR . | EZ-SIM vs ATOR . | SIM vs EZ-SIM . | |||||||
SIM (n = 337) . | EZ-SIM (n = 564) . | ATOR (n = 1510) . | HR (95% CI) . | P . | HR (95% CI) . | P . | HR (95% CI) . | P . | |
3-month follow-up | |||||||||
IS | 15 (4.5) | 16 (2.8) | 43 (2.8) | 1.35 (0.73–2.49) | .332 | 0.84 (0.46–1.55) | .576 | 1.61 (0.77–3.36) | .204 |
Death from any cause | 9 (2.7) | 7 (1.2) | 14 (0.9) | 3.14 (1.28–7.74) | .013 | 1.99 (0.76–5.22) | .162 | 1.58 (0.56–4.49) | .391 |
MI | 0 (0.0) | 3 (0.5) | 0 (0.0) | NA | NA | NA | NA | NA | NA |
Composite endpointa | 25 (7.4) | 25 (4.4) | 60 (4.0) | 1.62 (1.01–2.63) | .051 | 1.05 (0.65–1.72) | .836 | 1.54 (0.87–2.74) | .139 |
1-year follow-up | |||||||||
IS | 42 (12.5) | 42 (7.4) | 92 (6.1) | 1.91 (1.31–2.79) | .001 | 1.16 (0.80–1.70) | .439 | 1.64 (1.06–2.56) | .028 |
Death from any cause | 26 (7.7) | 20 (3.5) | 75 (5.0) | 1.56 (0.98–2.48) | .060 | 0.88 (0.53–1.46) | .616 | 1.78 (0.98–3.24) | .060 |
MI | 3 (0.9) | 6 (1.1) | 8 (0.5) | 1.47 (0.36–5.93) | .593 | 2.10 (0.66–6.71) | .211 | 0.70 (0.16–3.02) | .630 |
Composite endpointa | 67 (19.9) | 64 (11.3) | 173 (11.5) | 1.64 (1.23–2.20) | .001 | 1.04 (0.77–1.40) | .808 | 1.59 (1.11–2.26) | .011 |
Overall follow-up | |||||||||
IS | 57 (16.9) | 52 (9.2) | 114 (7.5) | 2.03 (1.46–2.82) | <.001 | 1.20 (0.85–1.69) | .296 | 1.69 (1.14–2.50) | .008 |
Death from any cause | 41 (12.2) | 35 (6.2) | 124 (8.2) | 1.26 (0.87–1.81) | .225 | 0.81 (0.55–1.20) | .297 | 1.54 (0.97–2.46) | .067 |
MI | 7 (2.1) | 6 (1.1) | 16 (1.1) | 1.71 (0.68–4.31) | .259 | 0.96 (0.36–2.58) | .942 | 1.77 (0.58–5.44) | .320 |
Composite endpointa | 95 (28.2) | 87 (15.4) | 243 (16.1) | 1.55 (1.22–1.99) | <.001 | 1.00 (0.77–1.28) | .978 | 1.56 (1.16–2.11) | .004 |
Outcome . | Number of Event (%) . | Adjusted Hazard Ratio and 95% CI . | |||||||
---|---|---|---|---|---|---|---|---|---|
SIM vs ATOR . | EZ-SIM vs ATOR . | SIM vs EZ-SIM . | |||||||
SIM (n = 337) . | EZ-SIM (n = 564) . | ATOR (n = 1510) . | HR (95% CI) . | P . | HR (95% CI) . | P . | HR (95% CI) . | P . | |
3-month follow-up | |||||||||
IS | 15 (4.5) | 16 (2.8) | 43 (2.8) | 1.35 (0.73–2.49) | .332 | 0.84 (0.46–1.55) | .576 | 1.61 (0.77–3.36) | .204 |
Death from any cause | 9 (2.7) | 7 (1.2) | 14 (0.9) | 3.14 (1.28–7.74) | .013 | 1.99 (0.76–5.22) | .162 | 1.58 (0.56–4.49) | .391 |
MI | 0 (0.0) | 3 (0.5) | 0 (0.0) | NA | NA | NA | NA | NA | NA |
Composite endpointa | 25 (7.4) | 25 (4.4) | 60 (4.0) | 1.62 (1.01–2.63) | .051 | 1.05 (0.65–1.72) | .836 | 1.54 (0.87–2.74) | .139 |
1-year follow-up | |||||||||
IS | 42 (12.5) | 42 (7.4) | 92 (6.1) | 1.91 (1.31–2.79) | .001 | 1.16 (0.80–1.70) | .439 | 1.64 (1.06–2.56) | .028 |
Death from any cause | 26 (7.7) | 20 (3.5) | 75 (5.0) | 1.56 (0.98–2.48) | .060 | 0.88 (0.53–1.46) | .616 | 1.78 (0.98–3.24) | .060 |
MI | 3 (0.9) | 6 (1.1) | 8 (0.5) | 1.47 (0.36–5.93) | .593 | 2.10 (0.66–6.71) | .211 | 0.70 (0.16–3.02) | .630 |
Composite endpointa | 67 (19.9) | 64 (11.3) | 173 (11.5) | 1.64 (1.23–2.20) | .001 | 1.04 (0.77–1.40) | .808 | 1.59 (1.11–2.26) | .011 |
Overall follow-up | |||||||||
IS | 57 (16.9) | 52 (9.2) | 114 (7.5) | 2.03 (1.46–2.82) | <.001 | 1.20 (0.85–1.69) | .296 | 1.69 (1.14–2.50) | .008 |
Death from any cause | 41 (12.2) | 35 (6.2) | 124 (8.2) | 1.26 (0.87–1.81) | .225 | 0.81 (0.55–1.20) | .297 | 1.54 (0.97–2.46) | .067 |
MI | 7 (2.1) | 6 (1.1) | 16 (1.1) | 1.71 (0.68–4.31) | .259 | 0.96 (0.36–2.58) | .942 | 1.77 (0.58–5.44) | .320 |
Composite endpointa | 95 (28.2) | 87 (15.4) | 243 (16.1) | 1.55 (1.22–1.99) | <.001 | 1.00 (0.77–1.28) | .978 | 1.56 (1.16–2.11) | .004 |
The HRs were adjusted for all covariates listed in Table 1 and Supplemental Table 2. NA, not applicable.
Any one of IS, HS, cardiovascular death, or MI.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.